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ABSTRACT 
Thin-section,  tracer,  and  freeze-cleave experiments on  hypophysectomized Rana 
pipiens larvae  reveal that gap junctions  form between  differentiating ependymo- 
glial  cells  in  response  to  thyroid  hormone.  These junctions  assemble  in  large 
particle-free areas of the plasma membrane known as formation plaques. Between 
20 and 40 h  after hormone application, formation plaque area increases approxi- 
mately 26-fold while gap junction  area rises about 20-fold. The differentiation of 
these junctions requires the synthesis of new protein and probably RNA as well. On 
the  basis  of  inhibitor  experiments,  it  can  be  reported  that  formation  plaques 
develop at about 16-20 h after hormone treatment and stages in the construction of 
gap junctions appear 4-8 h later. These studies suggest that gap junction subunits 
are  synthesized  and  inserted  into  formation  plaque  membrane  during  the 
differentiation of the anuran ependymoglial cells. 
Recent  observations  on  the  construction  of gap 
junctions in vitro (18) as well as in vivo (1, 3, 6, 35, 
36, 48) portray junctional precursors assembling in 
an  orderly fashion. Common features among de- 
veloping gap junctions include  the: (a) appearance 
of formation plaques  (18);  (b) clustering  and/or 
aggregation  of large  precursor  particles  accom- 
panying  a  reduction  of the  extracellular  space; 
(c)  polygonal packing of particles into  recogniz- 
able junctions;  and  (d)  enlargement  of junctions 
through the recruitment of nearby granules and/or 
fusion  of  smaller  aggregates  (I,  3,  6,  18,  36). 
Although minor variations on this theme may exist 
(3),  the  similarities are  truly  remarkable.  More- 
over, the developing gap junction provides an ideal 
model system to assess some of the macromolecu- 
lar  requirements  for  regional  plasma  membrane 
differentiation. 
While  a  morphological picture of gap junction 
assembly  is  slowly  emerging,  macromolecular 
events  concerned  with  the  control  of junctional 
differentiation  remain  to  be  elucidated.  In  one 
instance,  the coordinate  appearance of gap junc- 
tions and  electrotonic coupling  between  reaggre- 
gating Novikoff hepatoma cells (18) appears insen- 
sitive to drugs like cycloheximide (9) which inhibit 
protein synthesis.  In another, cycloheximide pre- 
vents cell-cell  interaction  between cultured  myo- 
blasts (47) and, therefore, may preclude the devel- 
opment of gap junctions  and low-resistance cou- 
pling (33) between  these cells. Events accompany- 
ing myoblast fusion (47) imply that the production 
of  new  membrane  proteins  is  essential  in  the 
development of multinucleate myotubes. The syn- 
thesis  and  insertion  of  gap  proteins  into  the 
myoblast  plasma  membrane  are  thought  to  be 
crucial in the coordination of myogenic cell fusion 
(33). 
The  present  experiments, employing hypophy- 
sectomized Rana pipiens larvae,  reveal that  the 
synchronous differentiation of ependymoglial cells 
requires  thyroid  hormones.  One  feature  of glial 
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junctions  between  adjacent  cells.  The  mode  of 
junctional  assembly  resembles  that  depicted  in 
reaggregation  of  Novikoff  hepatoma  cells  (18); 
however,  new  protein  synthesis  is  an  absolute 
requirement  for junctional  formation during thy- 
roxine-mediated glial differentiation. 
MATERIALS  AND  METHODS 
Animal Care 
All  tadpoles  were  reared and cared  for as described 
previously  (6).  When  the  embryos  reached  embryonic 
stage  17 (42) they were chosen for hypophysectomy. At 
this point in development, a  wedge  of pigmented ecto- 
derm,  including a  portion of the hypophyseal pit,  was 
surgically removed with glass needles and hair loops. The 
embryos were left in the operating medium (2￿  Holtfret- 
er's solution) for 30 min to  heal and  then returned to 
standard  Holtfreter's solution until they began to feed. 
Successfully hypophysectomized larvae revealed an un- 
pigmented or "silvery" appearance, and did not progress 
beyond Taylor and Kollros (45) stages VI or VII. Only 
those larvae which exhibited a steady rate of growth were 
employed in this investigation. 
Hormone Administration 
Stage  VII  tadpoles  with  hind  limb length  to  body 
length  ratios  of  less  than  0.05  were  given  a  single 
injection of 1.0 t~g/g body weight of DL-thyroxine (Sigma 
Chemical Company,  St.  Louis,  Mo.) intraperitoneally. 
Control larvae received 200 zN  NaOH  (the vehicle in 
which the hormone is suspended) instead of DL-thyrox- 
inc. The larvae were carefully staged (45) and preserved 
for light and electron microscopy at 4-h intervals through 
the first 48 h and, thereafter, at daily intervals. 
Morphology 
The  medullary  region  of selected  tadpoles  was  pre- 
served by vascular perfusion as reported earlier (6). The 
primary  fixative  consisted  of  1.67%  glutaraldehyde, 
1.33% paraformaldehyde, and 0.5%  acrolein buffered at 
pH  7,4  with  0.1  M  sodium  cacodylate.  Occasionally, 
2.5%  dimethylsulfoxide was added to facilitate penetra- 
tion  of  the  fixative.  In  some  experiments,  CaCI2  (25 
raM) was replaced by  1% potassium pyroantimonate in 
the  fixative  to  enhance junctional  staining;  in  others, 
heavy metal tracers, such as colloidal lanthanum (3%), 
potassium pyroantimonate (5%), or ruthenium red (500 
ppm), were administered in the fixative (6).  Larvae were 
perfused for 15--20 min and, after a 2-3-h delay, medul- 
lary  tissue  was  diced  and  fixation  was  continued  for 
another 8  h.  Tissues were  washed  overnight in 0.1  M 
cacodylate  buffer (pH  7.4)  with  7%  sucrose  and  then 
postfixed  in  I%  OsO,  plus  5%  sucrose  for  1-2  h. 
Subsequently, tissue slices were rinsed for I-2 h in 0.5% 
uranyl acetate (pH  5.5),  rapidly dehydrated in ethanol 
and propytene oxide, and embedded in Epon 812. 
Silver  or  gray  thin  sections  were  obtained  on  a 
Porter-Blum  MT-2  ultramicrotome,  (DuPont  Instru- 
ments, Sorvall Operations,  Newtown,  Conn.) equipped 
with  a  DuPont  diamond  knife (E.  J,  DuPont  de  Ne- 
mours, Inc., Wilmington, DeL). They were picked up on 
carbon-stabilized and  Formvar-coated  200-mesh grids, 
stained  in  5%  aqueous  uranyl  acetate  followed  by 
alkaline lead, and viewed  in a Siemens la or Philips 200 
electron microscope. 
Freeze Fracturing 
Small  pieces  of briefly (15  min) fixed  med~la  were 
immersed  in 0.1  M  cacodylate-buffered  (pH  7.4)  20% 
glycerol.  After the tissues had been treated for a  mini- 
mum  of 4  h  at 4~  they were  mounted on cardboard 
disks  and  rapidly  frozen  in  liquid  Freon  22  cooled  in 
liquid  nitrogen.  The  samples  were  then  fractured  at 
-115~  and  shadowed  with platinum and carbon in a 
Balzers'  apparatus  (BA360M,  Balzers  High  Vacuum 
Corp.,  Santa  Ana,  Calif.).  Replicas  were  cleaned  in 
sodium  hypochlorite  and  viewed  in  a  Siemens  la  or 
Philips 200 electron microscope. 
The  surface  area  of  A-face  membrane,  formation 
plaques,  and  gap junctions derived  from  replicas was 
determined with a compensating polar planimeter (model 
no. 620015,  Keuffel and Esser Co., Morristown, N. J.). 
Only  micrographs  which  revealed  formation  plaques 
and/or  gap  junctions  on  the  A  face  of  the  plasma 
membrane were selected and measured from each experi- 
ment.  B-face profiles were  not  utilized  because of the 
uncertainty  of  formation  plaque  boundaries  on  this 
portion of the cell membrane. The area  of the A-face 
plasma  membrane  which  represents  either  formation 
plaques  or  gap  junctions  is  expressed  as  formation 
plaque  or  gap junction  area  (square  micrometers) per 
100 #m 2 of A-face membrane. From each experimental 
animal,  at  least  10  plaque  regions  were  randomly  se- 
lected from available micrographs and measured. 
Incorporation of [3H]Uridine 
After the injection of a single dose of DL-thyroxine,  5.0 
uCi/g  body  weight of [5-SH]uridine (sp act 20.0 mCi/ 
mmole,  ICN  Isotope  and  Nuclear  Division,  Irvine, 
Calif.) were  administered intraperitoneally through the 
tail musculature to prevent leakage of the isotope. The 
nucleoside was injected 1 h before larval sacrifice at 0, 4, 
8,  12,  16, 20,  24,  36, or 48  h after hormone treatment. 
The ependymal epithelia of five tadpoles were carefully 
removed and homogenized in  1 ml of 50 mM Tris (pH 
7.4),  5  mM  MgCI:,  25  mM  KCI,  and 0.32  M  ribonu- 
clease-free sucrose. One aliquot of the homogenate was 
retained  to  measure  the  activity  of  the  acid-soluble 
nucleotide pool; the remaining portion was centrifuged at 
800 g  for 10 min. These samples were treated with 1 vot 
of ice-cold 0.6 N  perchloric acid (PCA). The sediments 
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washed twice in cold 0.2 N PCA, and the supernates were 
retained to measure the specific activity of the acid-solu- 
ble pool. 
A sample of the PCA-soluble extract was evaporated 
in a vacuum desiccator and the residue  was dissolved  in 
50 ~1 of water. This fraction was applied to a column of 
Dowex 50 W X4 (50-100 mesh) which had a bed volume 
of  1.0 ml and  a  void volume of 50 ~al. A  fraction was 
obtained that possessed 95-97% of the uridine derivatives 
and  radioactivity. This  fraction  was  used  to determine 
the specific activity of the nucleotide pool. 
The  acid-insoluble  extracts  (RNA  fractions)  were 
suspended  in 0.3 N KOH and incubated for 18 h at 37~ 
The hydrolysates were cooled, acidified with 0.7 N PCA, 
and centrifuged. The DNA and protein precipitates were 
subjected to two further washings in 0.2 N PCA, and the 
supernates  were combined  and  the optical density was 
determined at 260 nm in a Beckman DU spectrophotom- 
eter (Beckman  Instruments,  Inc., Fullerton, Calif.). An 
extinction  coefficient of 34.2  cm~/mg  was  adopted  to 
calculate RNA concentration (10). 
Samples  of acid-soluble  fractions  or  RNA extracts 
were neutralized with 1 N KOH to precipitate maximum 
amounts  of perchlorate,  and  aliquots of the supernates 
were  mixed with  5 ml of scintillation fluid  (2 parts  of 
toluene containing 0.4%  2,5-diphenyloxazole [PPO] and 
0.1%  1,4 bis-2-(5 phenyloxozolyl)-benzene [POPOP] and 
1 part Triton X-100).  Radioactivity was monitored in a 
Beckman LS-250 liquid scintillation counter. Alterations 
in  the  specific  activity  of the  acid-soluble  pool  were 
expressed as cpm/OD 260 rim, whereas the incorporation 
of tritiated uridine  into acid-precipitable material (RNA 
fraction) was expressed  as cpm/v.g of ependymal RNA. 
The relative rate of RNA synthesis  is defined as the ratio 
of  the  CPM  in  RNA  to  the  specific  activity  of the 
precursor pool per hour. 
At intervals of 0, 4, 8,  12, 16, and 20 h after thyroxine 
treatment,  other larvae were administered  1 ug/g body 
weight  of actinomycin  D  (gift of Merck,  Sharpe  and 
Dohme, Rahway, N. J.). These tadpoles were sacrificed 
at 4-h intervals.  I h before sacrifice, each animal received 
tritiated uridine,  and  the radioactivity in the nucleotide 
pool  as  well  as  in  the  PCA-precipitable  RNA  was 
measured as previously described. 
Incorporation  of [3H]Leucine 
The  incorporation  of  L-[4,5-SH]leucine  (sp  act  50 
Ci/mmol,  ICN  Isotope  and  Nuclear  Division,  lrvine, 
Calif.) into trichloroacetic acid (TCA)-precipitable pro- 
tein was determined at 0, 4, 8,  12,  16, 20, 24, 36, and 48 
h after hormone treatment. 30 min before sacrifice, each 
tadpole received l #Ci/g body weight of the isotope. The 
ependymae  of five larvae  were dissected  into  ice-cold 
20% TCA, homogenized, and then centrifuged. Changes 
in the amino acid pool size were assessed  by measuring 
the amount of radioactivity in the supernate of the TCA 
homogenate. The "20%" TCA residue was washed  and 
heated  in  5%  TCA  to  release  nucleic  acids,  and  then 
lipids were extracted with acetone followed  by a chloro- 
form-methanol  (2:1  vol/vol)  mixture.  The  insoluble 
material was dissolved in hot 1 N NaOH, and one aliquot 
was mixed with scintillation fluid while another was used 
to measure ependymal protein (24). 
1 h before the 12-, 16-, 20-, 24-, and 28-h intervals, 20 
#g/g  body  weight  of cycloheximide (Sigma  Chemical 
Co.) were injected intraperitoneally. Tadpoles were sacri- 
ficed at 4-h  periods during the succeeding  24 h, and  30 
min  before sacrifice each  larva  also  received  1 #Ci/g 
body weight of the isotope. Radioactivity was determined 
in the amino acid pool and the TCA-insoluble fraction as 
well. 
OBSERVATIONS 
Morphology  of " H  ypophysectomized" 
Ependymal Junctions 
Two  distinctive  cell  types  are  obvious  in  thin 
sections  and  freeze-fracture  replicas  of  the 
**hypophysectomized" medullary ependyma (Figs. 
I,  2).  One  is primarily ciliated (Fig.  1) while the 
other  displays  microvilli  of  varying  dimensions 
(Fig. 2). At the lumen of the epithelium, microvitli 
of adjacent  cells often  fold  over and  interdigitate 
with  one  another.  At  such  locales,  microvillar 
membrane structure is frequently modified in some 
fashion, with desmosomes, fasciae adherentes, and 
even gap junctions perceptible alterations.  In con- 
trast,  the junctional complex,  which adjoins these 
cells  at  their  apical  surface,  is  comprised  of  a 
zonula  adherens  (Fig.  1).  In freeze-fracture repli- 
cas (Fig.  2),  this region of the plasma  membrane 
discloses no distinguishing particle arrays or other 
unusual  modifications  (29).  Occasionally,  how- 
ever,  the  uniformity  of  the  adhering  zonule  is 
interrupted by a solitary gap junction (Fig. 1, inset; 
Fig. 2, inset) (6). The features of this pseudostrati- 
fled epithelium are retained  indefinitely unless the 
hypophysectomized  tadpole  receives thyroid  hor- 
mone(s). 
Influence of Thyroxine on 
Ependymal Junctions 
An  intraperitoneal  injection  of  oL-thyroxine 
elicits  profound  biochemical  and  morphological 
changes within anuran larvae in as little as 2,1-48 h 
(11).  Ependymal  cells  respond  by  elaborating 
numerous profiles of rough endoplasmic reticulum 
(32)  and  many  small,  dense-cored  vesicles which 
resemble the catecholamine granules described by 
R.  S.  DECKER  Thyroxine  and Gap Junctions  671 FIGURE  1  Morphology  of "hypophysectomized"  ependymal  cells. Microvilli  and  cilia are prominent 
features of the luminal surface. Adjacent cells are joined to one another  by a zonula adherens (ZA). The 
inset depicts a gap junction (G) which occasionally disrupts the continuity of the adhering zonule (ZA). x 
15,000; inset x  65,000. 
McKenna  and  Rosenbluth  (27,  28) in  subependy- 
mal cells of the toad hypothalamus. Alterations in 
the junctional configuration of these cells are most 
conspicuous  16-40  h  after  hormone  administra- 
tion. Thin sections reveal that the zonula adherens, 
which  interconnects  contiguous  neuroepithelial 
cells, is subdivided by several gap junctions (Fig. 
3).  Further, thin sectioning unveils lengthy regions 
of close apposition between lateral plasmalemmas 
of adjacent cells (Fig. 4).  Customarily, the width 
of this extracellular space ranges from  15 to 20 nm 
except  at  junctional  sites  (6);  however,  in  these 
zones the dimensions of this space may vary from 
somewhat over  10 nm downward to 2 nm (Fig. 5). 
En  face  views  of  lanthanum-impregnated  speci- 
mens further  illustrate small groups of negatively 
stained profiles scattered throughout these regions 
(Fig.  7).  Since  many  of these  structures  exhibit 
centrally stained spots and measure about 9  11 nm 
in diameter, they closely resemble the gap junction 
subunits  observed  by  others  (12,  29).  Profiles of 
gap  junctions  are  also  prevalent  in  such  areas 
(Figs. 4, 6). 
Freeze-fracturing uncovers extensive regions of 
particle-free  membrane  on  the  A  face  of  the 
plasma  membrane  16-40  h  after  an  injection  of 
thyroxine. Gap junctions in all phases of construc- 
tion can  be discerned within the confines of these 
areas  (Figs.  8-12).  Loosely  organized  clusters, 
small  aggregates,  polarized  arrays,  and  macular 
junctions are strikingly displayed in these immense 
"formation plaques" (18). The particles within the 
clusters  and  streams  measure  approximately  10 
nm,  whereas  the  granules  within  the  aggregates 
and unmistakable gap junctions range between 8.5 
and 9.0 nm in diameter (Fig. 10) (6). Although the 
plaques are not fully appreciated in B-face images, 
because  of  the  normally  sparse  distribution  of 
672  THE  JOURNAL OF  CELL  BIOLOGY  -  VOLUME  69,  1976 FIGURE 2  Freeze-cleaved appearance of the luminal surface of a "hypophysectomized" ependymal cell. 
Microvilli dominate the surface of this particular cell. The A face of the lateral plasma membrane displays 
numerous  heterogeneous  intramembrane  particles distributed  randomly,  while the  B face exhibits few 
particles, The inset illustrates a gap junction at the ependymal surface.  Polygonally packed particles of the 
A face and pits of the B face are portrayed here. Note the 100-A granules (arrow) nearby. ￿  40,000;  inset ￿ 
50,000. 
particles (29),  all developmental stages are visible 
(Figs. 9,  II,  12). 
A  quantitative  assessment  of  freeze-fracture 
replicas  reveals that  dramatic  increases  in forma- 
tion  plaque  and  gap  junction  area  transpire  be- 
tween  16 and 40 h after hormone application (Figs. 
13,  14).  The area  of A-face devoted to formation 
plaques  rises from  about  0.25  #m2/100  ~tm 2 of A 
R.  S.  DECKER  Thyroxine and Gap Junctions  673 FIGURE 3  Junctional  complex  of an  ependymat  cell 
treated  with thyroxine. K-pyroantimonate (1%) crisply 
stains gap junctions (arrowheads) which develop in the 
zonula adherens 36 h after hormone treatment. ￿  32,000. 
face in controls to approximately 6.5 um~/100 ,m ~ 
of A-face after  40 h  of hormone treatment  (Fig. 
13). This represents a 26-fold increase in formation 
plaque area on the A-face of the plasma membrane 
in  response  to  hormone.  Similarly,  the  area  en- 
compassed by gap junctions increases some 20-fold 
in  this  24-h  interim  (Fig.  14). in  absolute terms, 
6.5%  of the  A  face  of the  ependymoglial  mem- 
brane surface becomes transformed into formation 
plaques, while only 1.25% of the membrane consti- 
tutes  gap junctions.  Hypophysectomized controls 
and  normal  stage  Vll  larvae  receiving  a  placebo 
exhibit  no changes  in  either  formation plaque  or 
gap junction area during a similar period (Figs.  13, 
14). 
Thyroxine-Mediated Alterations in the 
Uptake and Incorporation of [sH]Uridine 
and [  3  H]Leucine 
Thyroid  hormones  regulate  many  aspects  of 
amphibian  development  (I 1).  In  particular,  the 
hormone mediates  the  regression  of some organs 
(21,  46)  and  the  differentiation  of  others  (5), 
ostensibly  through  a  mechanism  controlling  the 
synthesis of RNA and protein. The present report 
demonstrates  that  the  application  of antibiotics 
which are known to impede RNA (actinomycin D) 
or protein (cycloheximide) synthesis interferes with 
the hormonally promoted glial differentiation and 
the formation of gap junctions. 
One  early  response  to  thyroxine  is  a  marked 
change in the levels of radioactivity present in the 
acid-soluble  nucleotide  pool.  The  uridine  pool 
increases  gradually  during  the  first  8  h  after 
hormone treatment  and then exponentially in the 
succeeding  8  h  (Fig.  15  A,  Table  1).  At  this 
juncture,  acid-soluble  radioactivity  is  fourfold 
higher  than  the  controls  (zero  time  values), 
whereas  the  incorporation  of  [3H]uridine  into 
PCA-insoluble  material  (RNA  fraction)  is  ele- 
vated  only marginally.  However,  between  16 and 
24 h this pattern is reversed, with  the uridine pool 
labeling  declining  precipitously  as the  incorpora- 
tion  of  the  isotope  into  the  RNA  fraction  in- 
creases.  During the latter half of the experimental 
period, there is little  change in the specific activity 
of either the acid-soluble pool or the RNA fraction 
(Fig.  15 A, Table 1). Although precursor measure- 
ments of this  variety do not lend  themselves to a 
direct  determination  of absolute  synthetic  rates, 
one may calculate a  relative rate of synthesis (see 
Materials and Methods). Such a parameter reveals 
that there is a general decline in the rate of RNA 
synthesis during the first 16 h after the administra- 
tion  of thyroxine,  followed  by a  dramatic rise  in 
the succeeding 8 h (Fig.  15 B). These alterations in 
the relative rate of RNA synthesis accompany no 
overt changes in total  RNA content as measured 
by  the  Schmidt-Thannhauser  procedure  (Fig.  15 
B). 
The incorporation of [SH]uridine into the RNA 
fraction  is  inhibited  65-75%  (Table  i)  if  ac- 
tinomycin  D  is administered  simultaneously  with 
thyroxine. This inhibitory action is restricted  pri- 
marily to PCA-insoluble material since the specific 
activity of the acid-soluble pool remains essentially 
unchanged in response to the antibiotic (Table  1). 
Similarly,  introducing the drug at other  intervals 
has  much  the  same  effect,  i.e.,  inhibiting  the 
labeling  of  RNA  approximately  70%,  while  not 
influencing the specific activity of the pool (8). 
Alterations in the leucine pool and the incorpo- 
ration  of [3H]leucine  into the ependymal  protein 
are,  likewise,  dramatically  altered  by  thyroxine 
(Fig.  16). During the first 20 h there is a sigmoidal 
increase  in  TCA-soluble  pool  labeling  which  is 
followed by a gradual decline in pool radioactivity 
674  THE  JOURNAL OF  CELL  BIOLOGY  ￿9 VOLUME  69,  1976 FIGURES  4  and  5  Thin sections of probable formation plaques induced by thyroxine. Fig. 4 discloses a 
long region of close membrane apposition (brackets) which is apparent 24 h after hormone treatment, Gap 
junctions (arrowhead) are frequently seen  in such areas, A  lacy  network of microfilaments (mJ) is also 
evident subjacent to the plaque membranes. Fig. 5 illustrates a small portion of another plaque 22 h after 
hormone treatment, There are many points (arrows) at which the extracellular space is reduced to ~20 ,~; 
microfilaments  (mJ)  may  be  attached  to  the  outer  leaflets  at  such  sites  along  the  plaque.  CG, 
catecholamine-like granules. Fig. 4,  ￿  45,000;  Fig.  5,  x  150,000. 
FIGURES  6  and  7  Heavy metal tracers delineate the structure of the formation plaques. K-pyroantimon- 
ate (5%)  fills  the 20-~  extracellular space of a  gap junction in  a  plaque area  (Fig. 6).  Face views of 
specimens treated with lanthanum demonstrate several  small patches (arrows) which may represent gap 
precursor particles. Note the gap junction (G).  Fig. 6,  x  180,000; Fig. 7,  x  150,000. FIGURES 8 and 9  Freeze-fracture appearance of the A (Fig. 8) and B (Fig. 9) faces of formation plaques 
induced by thyroxine. At  28 (Fig. 8) or 30 (Fig. 9) h particle clusters (1), aggregates (2), "growing" 
junctions (3), and "macular" junctions (4) are visible within the smooth regions of the plaques. The author 
conceives of gap junctions passing through the four developmental stages with the cluster representing the 
earliest phase and the macular junction the most mature stage. Formation plaque area is confined within 
the limits of the dashed line. Fig. 8, ￿  40,000;  Fig. 9,  x 60~000 
during the subsequent 1.5 days. The incorporation 
of  [*H]leucine  into  the  TCA-insoluble  residue 
diminishes rather  slowly  for  16  h  and  then  in- 
creases  linearly  through  the  remainder  of  the 
experimental period (Fig.  16 A). The relative rate 
of protein synthesis falls to about 25% of control 
levels  (zero  time value) during the  first  16  h  of 
hormone treatment; then it increases significantly 
as exposure to the hormone continues (Fig. 16 B). 
A  sustained  decline  in  total  ependymal protein 
accompanies  the  changes  noted  in  the  teucine 
labeling of the amino acid pool and TCA-insoluble 
material (Fig.  16 A,  B). 
The injection of cycloheximide at several inter- 
vals after hormone treatment inhibits the incorpo- 
ration of [3H]leucine  into TCA-insoluble material 
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HOURS AFTER A SINGLE INJECTION  OF  DL-THYROXINE 
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FIGURE  13  Alterations  in  formation  plaque area as a 
function  of time after  a single  injection  of OL-thyroxine 
(T,)  or  NaOH.  Hypophysectomized  larvae  (r-l) were 
administered  T, at time zero, whereas other hypophysec- 
tomized  larvae  (1)  and normal  stage  VII controls (In) 
received  NaOH. Each square  represents the average  area 
of  10 plaques derived  from  one animal. 
FIGURES  10  12  A-  and  B-face  profiles  of developing 
gap  junctions  induced  by  thyroxine.  Fig.  10  depicts 
several  aspects of junctional assembly, including  cluster- 
ing (1),  aggregation  (2),  "growing"  (3),  and "macular" 
(4) junctions.  Figs.  11  and  12  illustrate  several  develop- 
mental stages in B-face images. ES, extracellular space. 
Figs.  10-12,  ￿  112,500. 
80-90% (Fig.  17 B), while not significantly altering 
the  labeling  patterns  of the  leucine pool (Fig.  17 
A). Only with  prolonged exposure (>20  h) is the 
specific  activity  in  the  acid-soluble  pool  affected 
(Fig.  17 A) by the drug. 
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FIGURE  14  Changes in gap junction area  as a function 
of time  after  a  single  injection  of DL-thyroxine  (T,)  or 
NaOH.  Hypophysectomized  larvae  (FI)  were  treated 
with  T,  at  time  zero;  while  other  hypophysectomized 
larvae  (1)  and normal  stage  Vll  controls  (In)  received 
NaOH  at  the  same  time.  Each  symbol  represents  the 
data acquired  from  one animal. 
Effects of  A ctinomycin D and Cycloheximide 
on Developing  Gap Junctions 
Though actinomycin D substantially inhibits  the 
incorporation of [SH]uridine  into  RNA  through- 
out development,  it  affects  the  formation of gap 
junctions only during  the first  12 h after hormone 
treatment.  Under  these  circumstances,  thin  sec- 
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FIGURE  15  A  Uptake  of [SH]uridine  into  PCA-solu- 
ble  (nucleotide  pool) and  PCA-insoluble (RNA)  frac- 
tions  of ependyma  after  treatment  with  DL-thyroxine. 
Each symbol is the average value of three experiments. 
B, Influence of OL-thyroxine on the relative rate of RNA 
synthesis, The rate (n) was derived from the data in Fig. 
15  A  (see  Materials  and  Methods).  Total  RNA  (at) 
measured by the Schmidt-Thannhauser procedure is also 
plotted.  Each  point is the  average of three determina- 
tions. 
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FIGURE  16  A  Uptake  and  incorporation  of [SHJleu- 
cine in TCA-soluble (amino acid pool) and TCA-insolu- 
ble (protein) fractions of ependyma after treatment with 
DL-thyroxine. Each point represents the average value of 
four experiments. B, The relative rate of protein synthesis 
(FI) and protein content (at) of ependyma after a  single 
injection  of DL-thyroxine.  Protein  was  assayed  by  the 
Lowry procedure.  Each  symbol is  an  average value of 
four experiments. 
TABLE  I 
Efjects of Actinornycin D (AMD)*  on the Uptake and Incorporation of [sH]Uridine$ 
Inhibition  of 
Specific  [sH]Uridine 
Time of  Number of  Acid-soluble  activity  uptake 
sacrifice  experiments  AMD  pool  of RNA  into RNA 
1  ug/g 
h  body wt  cpm/OD=,o~  cpm/y,g  RNAw 
0  3  -  2,440  21  0 
4  +  2,355  7  70% 
4  4  -  2,675  22  0 
4  +  2,720  7  69% 
8  3  -  3,630  23  0 
5  +  3,340  8  67% 
12  3  --  5,800  26  0 
4  +  5,410  7  72% 
16  4  -  8,260  32  0 
4  +  7,940  10  68% 
24  3  -  3,760  77  0 
3  +  3,550  27  65% 
36  3  -  3,970  92  0 
3  +  3,840  24  74% 
* All larvae received I vg/g body wt of DL-thyroxine at time 0 as well as 1 #g/g body wt of AM D 
(+) or 200 tzN NaOH (-)  at specified intervals. 
$ I h before sacrifice each larva was injected with 5 tzCi/g body wt of [3H]uridine. 
w All values are averaged. 
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FIGURE 17  A  Influence  of cycloheximide  (CHX)  on 
the uptake of [SH]leucine  into the TCA-soluble  pool after 
administration of OL-thyroxine. CHX was injected at 16 
(~), 20 ('~), or 24 (@) h and the amino acid pool activity 
was  determined  at  specified  intervals  (O  O  ~).  Each 
point  represents  the  average  of four  experiments.  B, 
Effect of cycloheximide (CHX) on the incorporation  of 
[SH]leucine into TCA-insoluble  fraction  (protein)  after 
hormone  treatment. The schedule of drug injection was 
identical to that for Fig. 17 A. Each value is an average of 
four experiments. 
tioning and freeze-cleaving disclose an undifferen- 
tiated  ependyma  with  only  a  few  randomly  dis- 
persed gap junctions.  At  a  time  when  formation 
plaques normally appear in response to thyroxine 
(16-20  h),  none  are  obvious  if  the  larvae  are 
treated  with  actinomycin  D  within  12  h  of hor- 
mone application. However, injection of the antibi- 
otic at  16 or  18 h after exposure to thyroxine does 
not markedly influence ependymoglial differentia- 
tion (appearance of rough endoplasmic reticulum 
and dense-cored granules) or the biogenesis of gap 
junctions. Particle clusters, aggregates, and macu- 
lar  junctions  are  prominent  in  freeze-fracture 
replicas (Fig.  18). 
in  contrast,  cycloheximide has  immediate and 
unequivocal effects on the formation of gap junc- 
tions. At doses (20 #g/g body weight) high enough 
to  inhibit the incorporation of leucine into TCA- 
insoluble material by 90%  (Fig.  17  B),  cyclohexi- 
mide halts junctional development at two  stages. 
Arresting protein synthesis before  16 h completely 
prevents the genesis of formation plaques and gap 
junctions (Figs.  19, 20).  Employing cycloheximide 
at 20 h, however, suppresses only the formation of 
developing junctions  and  not  the  appearance  of 
formation plaques (Figs. 19, 20).  Freeze-fracturing 
discloses  novel  alterations  in  the  A  face  of  the 
plasma membrane.  Normally, the A  face exhibits 
a  random distribution of heterogeneous particles; 
but  the  treatment  of larvae at  this juncture  with 
cycloheximide transforms the A  face into regions 
which  disclose  few  particles  and  others  which 
exhibit  high  particle  packing  densities  (compare 
Fig. 2 with Fig. 21). Although some ofthe particles 
in  these  smooth  areas  measure  100  A,  the  only 
evidence of assembling junctions is a  rare stream 
of large particles separating the two regions (Fig. 
21). Except for the absence of clusters, aggregates, 
and  differentiating junctions,  these  expanses  of 
smooth membrane resemble the formation plaques 
induced by thyroxine. As cycloheximide is utilized 
at later intervals, various stages in the development 
FIGURE 18  A-face  replica  of  a  30-h old  formation 
plaque  induced  by  thryoxine  followed  16  h  later  by 
actinomycin  D  treatment.  Developmental  stages  seen 
here are identical to those in Fig. 8.  x  43,000. 
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FIGURE  19  Influence of cycloheximide (CHX) on for- 
mation  plaque  area  after  the  administration  of  DL- 
thyroxine. CHX was injected at 12 (~'), 16 ('~), 20 (~), 
or  24  (~)  h  and  larvae  were sacrificed  at  specified 
intervals (11 [] I1 r-l). The area enclosed by the dashed 
line is the change in formation  plaque area induced by 
thyroxine in the absence of CHX. Each point represents 
the data obtained from a single animal. 
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FIGURE 20  Effect of  cycloheximide  (CHX)  on  gap 
junction  area after treatment with OL-thyroxine. CHX 
was administered at 12 (~), 16 (,~), 20 (~), or 24 (~) h 
and larvae were sacrificed at specified intervals (11 [] [] 
r'l). The area outlined by the dashes represents the change 
in gap junction area induced by thyroxine in the absence 
of CHX. Each point is the data derived from one animal. 
of the junctions can be recognized. Between 22 and 
24  h,  clusters (Fig. 22) and small aggregates may 
be  readily appreciated in  freeze-fracture replicas. 
When administration of the drug is delayed beyond 
24 h, small variegated gap junctions are frequently 
observed within plaque regions (Fig. 23). 
DISCUSSION 
The  development  of  the  amphibian  neuroepi- 
thelium  can  be  subdivided  into  two  distinct  pe- 
riods, one of which  requires thyroid hormone for 
its initiation. In the first, neurons are apparently 
generated in the ventricular zone and subsequently 
migrate  peripherally into  intermediate grey mat- 
ter. The second period, which is dependent on the 
presence of thyroid hormone, mediates ependymo- 
glial differentiation (32).  One  facet  of the  epen- 
dymoglial  response  involves the  development  of 
gap junctions between contiguous neuroglial cells. 
Moreover,  the  propagation  of  these  junctions 
seems to require the synthesis of new protein which 
may  be  predicated on  an  earlier period of RNA 
synthesis. 
Gap Junction Differentiation 
This study as well as others (3,  18) confirms our 
previous impressions (6) that the formation of gap 
junctions  proceeds  in  discrete  steps.  As early as 
16-20  h  after  a  single injection of DL-thyroxine, 
large formation plaques (18) appear between adja- 
cent ependymoglial cells. Within the limits of these 
plaques,  all aspects of gap junction assembly are 
perceptible (Figs. 8,  10). Large clusters of 10-rim 
particles  previously  described  in  reaggregating 
Novikoff hepatoma cells (18) are confirmed in this 
report. Small particle aggregates as well as dimin- 
utive arrays displaying a  variety of contours  are 
also  prominent  (Fig.  8)  and  probably  represent 
stages in the formation of gap junctions (6, 18, 36). 
Similarly, thin sections reveal unusual expanses of 
cell-cell contact in which the extracellular space is 
reduced  to  10  nm  or less (Figs. 4,  5).  It is these 
areas, in all likelihood, which denote the formation 
plaques  described  here  and  those  reported  by 
Johnson  et  al.  (18).  A  preliminary  report  from 
Johnson's laboratory (I 7) further discloses that the 
invertebrate hormone, ecdysterone, apparently al- 
ters the particle packing density and morphology 
of  Limulus gap  junctions  (19).  Here,  loosely 
packed arrays recognized from  I  to  3 days after 
hormonal administration are interpreted as reflect- 
ing a phase of gap junction development. 
The origin of the  10-rim gap precursor particles 
is still a moot issue. These large particles which are 
so  characteristic of differentiating junctions  are 
rarely  encountered  in  freeze-fracture  replicas  of 
mature  tissues  (12,  29).  However,  subjecting  rat 
liver hepatocytes to hypertonic shock has demon- 
680  THE  JOURNAL  OF  CELL  BIOLOGY  ￿9  VOLUME  69,  1976 FIGURE 21  A-face replica of the transition zone between a formation plaque (FP)  induced by thyroxine 
followed  by cycloheximide  treatment at 20 h  with  fixation at 26 h. Note the sharp distinction between 
"normal" A  face  and the plaque region  and the large particles dispersed  somewhat  haphazardly in the 
plaque (FP).  At the boundary between the A face and the plaque, a row of 100-/~ granules (arrowheads)  is 
visible.  ￿  50,000. 
FIGURE 22  A-face profile of a formation plaque (FP) in which larva received cycloheximide  at 22 h and 
was fixed at 28 h after hormone. Two clusters of 100-.~ granules can be discerned (arrowheads) in this large 
formation plaque. The "normal" A face is also pictured. ￿  45,000. 
strated the existence of a  similar class of particles 
residing  around  the  periphery  of  gap  junctions 
(15).  Perhaps,  as  the  junction  is  disrupted,  the 
conformation  of  its  outer  particles  is  altered, 
revealing their larger dimension. Similarly, in the 
assembly of the junction, changes in particle size 
may accompany the polygonal packing of subunits 
into recognizable junctions (6,  18). 
R.  S.  D~CKER  Thyroxine  and Gap Junctions  681 FIGURE 23  Another  A-face  image  of  a  formation 
plaque in which the larva received cycloheximide at 28 h 
and was fixed at 38 h after hormone. Particle arrays and 
two  gap junctions (G)  are  apparent  in  the  formation 
plaque. Note the A face nearby.  ￿  50,000. 
Macromolecular Synthesis during Gap 
Junction Assembly 
Although gap junctions may develop independ- 
ently  of protein  synthesis in  reaggregating Novi- 
koff hepatoma cells (9, 40), there appears to be an 
obligatory  requirement  of  new  protein  synthesis 
for  the  assembly  of junctions  during  thyroxine- 
stimulated  ependymoglial  differentiation.  Cy- 
cloheximide  as  well  as  actinomycin  D  markedly 
influences junctional development if administered 
at the proper time after hormone treatment. 
Inhibiting protein synthesis with cycloheximide 
(Fig.  17  B) at  various intervals after the injection 
of thyroxine may directly affect the development 
of formation  plaques  and  the  production of gap- 
junction  subunits.  Formation  plaques  as  well  as 
gap junctions  fail  to  appear  if cycloheximide  is 
employed at 16 h after hormone treatment. Freeze- 
cleaving reveals an A face which exhibits a hetero- 
geneous  class  of  randomly  dispersed  particles. 
Likewise, thin  sections fail to illustrate the elabo- 
rate  regions  of  close  cell-cell  contact  that  are 
common at this juncture. At 20 h some formation 
plaques  are evident (Fig. 21),  but gap precursors 
are  not  yet  visible  and  there  appears  to  be  no 
thin-section correlate of these plaques. The bound- 
ary  between  the  plaque  and  "normal"  A-face 
membranes  is  sharp  and  well  defined,  rarely 
displaying a linear arrangement of 10-nm granules 
(Fig. 21).  Between 22  and  24  h,  clusters (Fig. 22) 
and small aggregates appear; however, if cyclohex- 
imide treatment is delayed to 24 h or later, then the 
formation plaques reveal clusters, aggregates, and 
recognizable gap junctions (Fig. 23). This sequen- 
tial inhibition of plaque formation and junctional 
assembly  suggests  that  the  production  of  new 
protein(s) is a prerequisite for both development of 
the plaques and the differentiation of junctions. 
Alternatively,  it  is  also  conceivable  that  cy- 
cloheximide may primarily interfere with cell-cell 
interactions and only secondarily with the produc- 
tion  of  gap  junctions;  thus,  the  suppression  of 
cell-cell recognition  and  subsequent  contact  may 
obstruct the development of gap junctions between 
differentiating  glia.  The  inhibition  of  myoblast 
contact  in  vitro  with  cycloheximide  (47)  could 
prevent  the  genesis  of  gap  junctions  and  the 
establishment of low-resistance coupling (33, 34) in 
such a fashion. In other instances, the inhibition of 
protein  synthesis  is  known  to  impede  histotypic 
cell  reaggregation  of  trypsinized  chick  embryo 
brain cells (22, 25, 30,  31).  It is probable that this 
cycloheximide-sensitive step  may  involve the  re- 
newal of an aggregating factor on the cell surface 
which  is altered through the proteolytic action of 
trypsin  (2,  22,  26).  However,  it  must  be empha- 
sized that the inhibition of protein synthesis during 
the  first  1  or  2  h  of  reaggregation  has  little 
noticeable  influence  on  the  appearance  of  gap 
junctions  (41).  Ethylenediamine  tetraacetate 
(EDTA),  which  is  also  commonly  employed  to 
dissociate embryonic and cultured cells, has mini- 
mal effects on the early phases of cell aggregation 
(18, 25).  In such experiments, cell-cell interactions 
and gap junction formation occur for at least 2 h 
in  the  absence  of  protein  synthesis  (9).  If  gap 
junction  particles  represent  integral  membrane 
proteins (13,  14,  16, 44), then it is unlikely that the 
dissociation of Novikoff hepatoma cells in EDTA, 
for  example,  would  result  in  their  removal from 
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of extraceilular  cations, such as calcium (23,  37), 
or the alteration  of some other factor may affect 
the  distribution  of gap  particles  possibly  by dis- 
rupting  their  extracellular  channels  (4).  Resus- 
pending such cells  in  aggregation  medium would 
resupply  this  vital  constituent  and  initiate  junc- 
tional formation in the absence of protein synthesis 
(9, 40). 
Direct comparisons of junctional  assembly  be- 
tween reaggregating cell  systems and differentiat- 
ing  gila  must  be  interpreted  with  caution.  Since 
gap junctions are known to join embryonic (4,  7) 
and Novikoff hepatoma (20) cells  before dissocia- 
tion, perhaps a limited pool of gap precursors and 
aggregating  factors  reside  in  the  plasma  mem- 
branes of the separated cells,  so that cell reaggre- 
gation and gap-junction development may be sus- 
tained  for at  least  2  h  in  the absence of protein 
synthesis.  Conversely,  ependymoglial  cells  first 
appear  in  response  to  thyroid  hormone  (28). 
Consequently,  glial  differentiation  would,  out of 
neccessity,  require  membrane  differentiation 
which could  include  the elaboration  of glial-glial 
recognition  factors and  gap junctions.  Under  the 
present circumstances, it is not possible to discern 
whether  the  inhibition  of protein  synthesis  with 
cycloheximide is initially affecting cell-cell  recog- 
nition, junctional formation, or both. 
Actinomycin D only affects junctional assembly 
during  the  first  12  h  after  hormone  treatment. 
Although this antibiotic only inhibits the incorpo- 
ration of [3H]uridine into acid-precipitabte  RNA 
approximately 70%,  it fully prevents the develop- 
ment  of  formation  plaques  and  gap  junctions. 
Nevertheless, if application of the drug is delayed 
beyond  12  h, ependymoglial cells  apparently dif- 
ferentiate normally with formation plaques exhib- 
iting features that are indistinguishable  from thy- 
roxine-treated  controls (Fig.  18). Even though no 
attempt was made to characterize new ependymal 
RNAs, the observations of Ryffel and Weber (38, 
39) indicate that thyroxine enhances the synthesis 
of tadpole brain ribosomal and transfer RNA, but 
apparently  does  not  induce  the  production  of 
RNAs  with  messenger  qualities.  Whether  gap 
proteins  or  any  other  proteins  associated  with 
junctional  formation  are  translanted  from newly 
constructed cytoplasmic ribosomes or rough endo- 
plasmic  reticulum  (32)  requires  further  investiga- 
tion; however, the effects of actinomycin D allude 
to the need for a template. 
This  investigation  concludes that  the  assembly 
of  gap  junctions  between  differentiating  epen- 
dymoglial  cells  is  enhanced  by  thyroxine.  The 
hormone-mediated development of these junctions 
requires the synthesis of new protein which appears 
essential  to  the  genesis  of formation  plaques  as 
well  as the  production  of gap junction  subunits. 
The  temporal  appearance  of formation  plaques 
followed  by  their  population  with  gap  junction 
precursors and developing junctions suggests that 
gap  subunits  are  synthesized  de  novo  and  then 
inserted in some fashion into the formation plaque 
membrane. 
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